Online inquiry

IVTScrip™ mRNA-Human ATAD3C, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25140MR)

This product GTTS-WK25140MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATAD3C protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001039211.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 219293
UniProt ID Q5T2N8
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATAD3C, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25140MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14248MR IVTScrip™ mRNA-Human ACSL4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACSL4
GTTS-WK16027MR IVTScrip™ mRNA-Human ALKBH6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALKBH6
GTTS-WK3072MR IVTScrip™ mRNA-Human CD292, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA CD292
GTTS-WK9734MR IVTScrip™ mRNA-Human ACOT2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACOT2
GTTS-WK6730MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK11214MR IVTScrip™ mRNA-Human ACAT2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACAT2
GTTS-WK13194MR IVTScrip™ mRNA-Human AGBL5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AGBL5
GTTS-WK9124MR IVTScrip™ mRNA-Human Acetylcholinesterase, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA Acetylcholinesterase
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW